DPU - Symposium 2022

analyse small portions of tumour tissue, which still doesn’t allow for a complete characterization of the tumour genomic landscape. Therefore, radiomics has great potential for a comprehensive evaluation of the entire tumour burden as it is non-invasive and is already often repeated during treatment in routine practice. Radiomics (on both CT and MRI) can quantify such spatial and temporal heterogeneity, potentially providing “virtual biopsies”. Integration of radiomics with other multi-omics data is crucial for precision oncology.